Rep. Deborah K. Ross

Maddy summaryThis bill establishes comprehensive name, image, and likeness (NIL) rights for college athletes, prohibiting institutions from restricting athletes' ability to earn compensation for their personal branding or taking adverse action against them for doing so. It requires transparent NIL agreements for compensation over $600, including specific details about services, compensation amounts, and termination terms. The bill also amends immigration laws to better accommodate international student athletes participating in college sports and updates regulations governing sports agents. Additionally, it establishes a Commission to study college athletics governance, focusing on collective bargaining, revenue sharing, and Title IX compliance, while expanding disclosure requirements for colleges regarding athletics revenue and expenses.

Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.  Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.  The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

Maddy summaryThe Tri-Share Child Care Pilot Act of 2025 would establish a 3-year federal pilot program to test shared-cost child care assistance across three parties. It would require states to create programs where eligible parents (with children meeting income limits and age requirements), participating employers, and state lead agencies each pay one-third of qualifying child care costs. The program would be funded with $250 million annually, with states applying for grants to administer the initiative and verify eligibility through employer-parent agreements. The pilot aims to improve child care affordability and access for working families while requiring states to evaluate its impact on employment and child care availability.

Maddy summaryHRES 909 is a House resolution affirming that immigrant justice and reproductive justice are interconnected and must be addressed together. It calls on the Department of Homeland Security to reinstate protections for pregnant individuals in detention, eliminate the 5-year bar restricting immigrants’ access to federal health programs like Medicaid, and implement transparent oversight of reproductive health care in detention facilities. The resolution also urges Congress to remove barriers to health care access for immigrants and requires federal agencies to report on policies affecting reproductive health care for detained individuals. This resolution directly affects policies toward immigrants in detention, particularly regarding access to abortion, prenatal care, and mental health services, but does not create new laws.

Maddy summaryHR 6181, the John Lewis Every Child Deserves a Family Act, prohibits child welfare agencies receiving federal funds from discriminating against children, youth, or prospective foster/adoptive parents based on religion, sex (including sexual orientation and gender identity), or marital status. It directly affects LGBTQ youth in foster care - overrepresented at 30% of the system - who face higher risks of trauma, group home placements, and suicide attempts compared to non-LGBTQ peers. Key provisions require agencies to collect data on sexual orientation and gender identity, establish a National Resource Center for LGBTQ youth support, provide cultural competency training, and eliminate discriminatory practices. The law aims to improve safety, permanency, and placement stability by expanding access to family-based care and ensuring equitable services for all children in the system.

Maddy summaryHR 6126 authorizes the minting of commemorative coins to mark the 100th anniversary of the U.S. Foreign Service (established in 1924). It specifies three coin types: up to 50,000 $5 gold coins (90% gold), 400,000 $1 silver coins (90% silver), and 750,000 half-dollar coins, all to be sold during 2029. A surcharge of $35 per gold coin, $10 per silver coin, and $5 per half-dollar is added to the sale price, with all surcharge funds directed to the Association for Diplomatic Studies and Training to support its diplomatic history preservation work. The coins must include standard inscriptions (e.g., "Liberty," "United States of America") and will be legal tender, but the bill does not create new policy or affect government operations.

Maddy summaryThe FAIR Act requires immigration detention centers to provide detained immigrants with access to forms needed to contact their congressional representatives, including a Privacy Waiver form (ICE Form 60-001) and a Congressional Privacy Release form, upon written request. Detainees must receive these forms and a multilingual handbook explaining constituent services within 90 days of the bill’s enactment, with the handbook provided in their language or via interpreter. Centers must notify the detainee’s congressional office within seven days of a request and allow access to communication tools like computers and printers for ongoing contact. Failure to comply allows detainees to file complaints or sue in federal court, with enforcement mechanisms detailed in the bill. The law takes effect 90 days after enactment.

Maddy summaryThis bill establishes a pilot program requiring the Secretary of Defense to partner with certified nonprofit diaper banks to provide free diapers and diapering supplies to military families in need. Covered diaper banks must be nonprofit members of the National Diaper Bank Network with at least five years of experience distributing diapers at no cost. The program will connect these banks directly with military installations to address diaper access gaps, with the National Diaper Bank Network providing technical support and evaluating the pilot's effectiveness. It directly affects military families facing financial barriers to basic necessities like diapers, creating a new federal partnership mechanism for support.

Maddy summaryThe Global Respect Act (HR 6151) requires the U.S. President to publicly list foreign officials responsible for severe human rights violations against LGBTQI individuals, including torture, prolonged detention, or violence based on sexual orientation or gender identity. It mandates denying visas and entry to listed individuals and requires annual reports on the list's updates and impacts. The bill also directs the State Department to track global violence against LGBTQI people and update annual human rights reports to include discrimination based on sexual orientation or gender identity. These provisions directly affect foreign government officials and entities implicated in such abuses, aiming to increase accountability through U.S. visa restrictions.

Maddy summaryThe Biomanufacturing Excellence Act of 2025 establishes a National Biopharmaceutical Manufacturing Center of Excellence under the National Institute of Standards and Technology (NIST). It authorizes $120 million in funding for fiscal year 2026 to competitively award a grant to eligible entities - such as public-private partnerships, universities, or consortia - to create this center. The center will advance biopharmaceutical manufacturing technology, strengthen U.S. supply chains for medicines, and develop workforce training programs, with a focus on products critical to national security, health, and economic security. It requires annual progress reports to Congress and mandates the center to collaborate with manufacturers, research institutions, and educational partners to scale innovative production methods.